EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Amedisys's enterprise value is $3,517 Mil.
Amedisys's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $2,251 Mil. Therefore, Amedisys's EV-to-Revenue for today is 1.56.
The historical rank and industry rank for Amedisys's EV-to-Revenue or its related term are showing as below:
AMED'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.29 Med: 1.54 Max: 5.15
Current: 1.56
During the past 13 years, the highest EV-to-Revenue of Amedisys was 5.15. The lowest was 0.29. And the median was 1.54.
AMED's EV-to-Revenue is ranked better than 56.67% of 660
companies
in the Healthcare Providers & Services industry
Industry Median: 1.83
vs AMED: 1.56
As of today (2024-05-22), Amedisys's stock price is $96.77.
Amedisys's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $68.73. Therefore, Amedisys's PS Ratio for today is 1.41.
Amedisys EV-to-Revenue Historical Data
The historical data trend for Amedisys's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Amedisys's EV-to-Revenue
For the Medical Care Facilities subindustry, Amedisys's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amedisys's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Amedisys's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Amedisys's EV-to-Revenue falls into.
Amedisys's current Enterprise Value is $3,517 Mil.
Amedisys's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,251 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amedisys's share price for today is $96.77.
Amedisys's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $68.73.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amedisys EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Amedisys's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AMED has been successfully added to your 